Search
INmune Bio Inc
INMBAdd to Watchlist
2.330USD
+0.150+6.88%
Close 09-18 16:00（ET）
64.99MMarket Cap
LossP/E TTM
TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D
Today
+6.88%
5 Days
+0.87%
1 Month
+9.39%
6 Months
+82.03%
Year to Date
+49.36%
1 Year
+21.99%
Key Figures
2.220Open
2.395High
45.16KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.16%Turnover Ratio
2.180Prev. Close
2.240Low
104.72KTurnover
LossP/E Static
3.19P/B
0.00%Div Yield TTM
-130.78%ROA
2.60052wk High
38.39Volume Ratio
-42.08MNet Profit
27.65MShares
-1.6258EPS TTM
1.04Beta
-168.78%ROE
1.09052wk Low
7.11%Amplitude
100.00%Gross Margin
64.99MMarket Cap
2.12Reward/Risk
4.58%Risk Rate
INmune Bio Inc's Score
0.10vs previous score
Forecast8.00
Financial Health7.63
Technical4.93
Valuation Dimensions6.26
Institutional Confidence3.00
Risk Assessment2.60
Media Coverage
Coverage Level
Very Low
Very High
Positive
Analyst Rating
INmune Bio Inc Technical Analysis
Technical Indicators
Buy
Summary
Buy
Moving Average
Strong buy
Financial Indicators
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
Earnings
Next reporting date
--
Reporting Period
2026Q2
Earnings / Forecast
-0.05/-0.21
Revenue / Forecast
0.00/0.00
INmune Bio Inc Profile
SectorBiotechnology & Medical Research
Ticker SymbolINMB
Number of employees22
CountryUnited States of America
Ownership
| Shareholders | Proportion |
|---|---|
| Lowdell (Mark William) | 5.68% |
| Moss (David J.) | 4.84% |
| BlackRock Institutional Trust Company, N.A. | 4.21% |
| Vanguard Capital Management, LLC | 2.58% |
| Shareholder Types | Proportion |
|---|---|
| Investment Advisor | 12.45% |
| Individual Investor | 11.16% |
| Investment Advisor/Hedge Fund | 4.53% |
| Research Firm | 0.86% |
Related Instruments
+0.04%
-0.09%
-0.04%
-0.02%
-0.19%
-0.39%
+1.55%
-0.52%
+0.07%
+0.12%
+0.35%
-1.55%
-1.65%
-1.53%
-0.56%
-0.58%
-0.55%
-2.55%
-0.73%
-0.42%Popular Instruments
51734.000
-26.000 (-0.05%)
29664.700
+252.000 (+0.86%)
7659.100
+27.000 (+0.35%)
14420.000
+119.000 (+0.83%)
65079.000
+130.000 (+0.20%)
6230.800
-76.400 (-1.21%)
96.001
-1.985 (-2.03%)
336.130
-0.870 (-0.26%)
222.270
+2.930 (+1.34%)
4377.330
+36.350 (+0.84%)
FAQs
What is the current price of INmune Bio Inc (INMB)?
The current price of INmune Bio Inc (INMB) is 2.18.
What is the symbol of INmune Bio Inc?
The ticker symbol of INmune Bio Inc is INMB.
What is the 52-week high of INmune Bio Inc?
The 52-week high of INmune Bio Inc is 2.60.
What is the 52-week low of INmune Bio Inc?
The 52-week low of INmune Bio Inc is 1.09.
What is the market capitalization of INmune Bio Inc?
The market capitalization of INmune Bio Inc is 60.15M.
Is INmune Bio Inc (INMB) currently rated as Buy, Hold, or Sell?
According to analysts, INmune Bio Inc (INMB) has an overall rating of Buy, with a price target of 8.00.
What is the Earnings Per Share (EPS TTM) of INmune Bio Inc (INMB)?
The Earnings Per Share (EPS TTM) of INmune Bio Inc (INMB) is -1.63.